SCHEMBL2484470

SCHEMBL2484470

Cc1ccc(S(=O)(=O)O)cc1CC1CCCO1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.45
SLC12A2 P55011 1/20 0.44
SLC12A5 Q9H2X9 1/20 0.44
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
RAB9A P51151 2/20 0.43
HTT P42858 2/20 0.43
NR2F2 P24468 1/20 0.43
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.42
POLB P06746 2/20 0.42
KMT2A Q03164 1/20 0.42
GAA P10253 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 2/20 0.41
CXCR4 P61073 1/20 0.40
PKM P14618 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537493 0.84 KMT2A (0.38) ALDH1A1HTTKMT2AGAALMNA
SCHEMBL3673653 0.84 KMT2A (0.38) ALDH1A1HTTKMT2AGAALMNA
SCHEMBL2364146 0.83 USP2 (0.41) ATMALDH1A1SMN1; SMN2ALOX12KDM4E
SCHEMBL7735410 0.80 ALDH1A1 (0.40) ALDH1A1HTTKMT2AGAATDP1
SCHEMBL5153698 0.80 CA1 (0.34) ATMALDH1A1HTTKMT2AGAA
SCHEMBL2484468 0.77 KDM4E (0.46) SLC12A2SLC12A5ALDH1A1SMN1; SMN2RAB9A
SCHEMBL2484523 0.77 PIK3CD (0.36) ALDH1A1KMT2A
SCHEMBL965090 0.77 KDM4E (0.46) SLC12A2SLC12A5ALDH1A1SMN1; SMN2RAB9A
SCHEMBL26641101 0.76 SNCA (0.36) ALDH1A1GAALMNA
SCHEMBL7846676 0.75 PIK3CD (0.35) ALDH1A1SMN1; SMN2HTTTSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8513162-B2 Halogen-containing organosulfur compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-08-20 US disclosed
US-20110257226-A1 HALOGEN-CONTAINING ORGANOSULFUR COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-10-20 US disclosed
EP-2376450-A1 HALOGEN-CONTAINING ORGANOSULFUR COMPOUNDS AND USE THEREOF FOR CONTROLLING ARTHROPOD PEST Sumitomo Chemical Company, Limited (JP) 2011-10-19 EP disclosed
WO-2010074327-A1 HALOGEN-CONTAINING ORGANOSULFUR COMPOUNDS AND USE THEREOF FOR CONTROLLING ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257226-A1 HALOGEN-CONTAINING ORGANOSULFUR COMPOUND AND USE THEREOF C1S, C5, L3MBTL3 ATM 3906/4885SLC12A2 1685/4885SLC12A5 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.